Health
Study shows Oxford Covid vaccine has less protection against South African variant – The Guardian
Researchers say vaccines’ focus must shift to protecting people from hospitalisation and death
The Oxford/AstraZeneca vaccine will not stop people becoming ill if they contract the South African variant of Covid-19, researchers have confirmed, warning that vaccines focus needs to shift from population immunity to protecting individuals from hospitalisation and death.
The small study in 2,000 people aged 31, who are less likely to become severely ill, adds to evidence from big trials of other vaccines carried out after the variant appeared in South Africa. Trial data from the Janssen and Novavax…
-
General11 hours agoByford rail extension opening marks final stage of Perth Metronet
-
Noosa News17 hours agoFatal traffic crash, Baringa – Sunshine Coast
-
General23 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
General13 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery